Free Trial

USD/KRW has dived on the back of a.......>

KOREAN WON
KOREAN WON: USD/KRW has dived on the back of a wider risk-on reaction to the
reports about a successful trial of Moderna's Covid-19 vaccine. The pair trades
-5.30 fig. at KRW1,200.45.
- The won may have drawn some support from the fact that South Korea's
unemployment slipped to 4.3% from 4.5% in June, even as median BBG forecast was
for no change. The data comes after the gov't pledged to unleash massive
spending to rescue the economy.
- On Tuesday, President Moon announced that the size of his "New Deal" spending
plan will be doubled to KRW160tn. The plan aims at creating 1.9mn new jobs over
the next five years.
- Bears need a break below the 200-DMA at KRW1,197.00 before taking aim at Jul 7
low of KRW1,189.80. Bulls see yesterday's peak at KRW1,207.75 as their initial
target and a break here would expose the 50-DMA at KRW1,213.80.
- Looking ahead, the BoK delivers its monetary policy decision on Thursday.

To read the full story

Close

Why MNI

MNI is the leading provider

of intelligence and analysis on the Global Fixed Income, Foreign Exchange and Energy markets. We use an innovative combination of real-time analysis, deep fundamental research and journalism to provide unique and actionable insights for traders and investors. Our "All signal, no noise" approach drives an intelligence service that is succinct and timely, which is highly regarded by our time constrained client base.

Our Head Office is in London with offices in Chicago, Washington and Beijing, as well as an on the ground presence in other major financial centres across the world.